In addition, increased MPO levels have been shown to predict the future risk of CAD in apparently healthy individuals, indicating that MPO-catalyzed inflammatory activation precedes the onset of overt CAD by many years [47]. The gene discussed is MPO; the disease is coronary artery disorder.